Hospital Resource Use in below-Knee Surgical Bypass Procedures with Eptfe Vascular Grafts with Heparin End-Point Covalent Bond in Critical Limb Ischemia Peripheral Arterial Disease (PAD) Patients

Author(s)

Iqbal K1, Pons M2
1WL Gore & Associates Ltd, Livingstone, WLN, UK, 2W.L. Gore y Asociados, S.L., Barcelona, Spain

Presentation Documents

OBJECTIVES:

PAD is mainly caused by atherosclerosis that reduces blood flow to the limbs. Prosthetic vascular grafts are frequently used in lower limb bypass procedures in occluded or stenosed arteries. This study reviewed the hospital resource use reported in published literature for below-knee surgical bypass procedures using the GORE® PROPATEN® Vascular Graft with heparin end-point covalent bond.

METHODS:

A literature review of studies on GORE® PROPATEN® Vascular Graft with heparin end-point covalent bond was conducted. Articles were included if they were on below-knee bypass procedures on critical limb ischemia patients, published after 2010 and reported any type of hospital resource use e.g., hospital stay. Registries were excluded due to high risk of bias. Data was extracted and pooled using a weighted average method.

RESULTS:

11 articles were reviewed and there were four articles in the final selection. Three studies reported hospital stay (n = 323 patients) and four studies reported operating room time for the bypass procedure (n = 340 patients). No other hospital resource use was reported. For below-knee surgical bypass procedures using the GORE® PROPATEN® Vascular Graft with heparin end-point covalent bond, the weighted average hospital stay was 6.6 days (per patient) and operating room time was 138 minutes (per patient).

CONCLUSIONS:

Clinical outcomes such as patency and complications are consistently reported in studies. Outcomes on hospital resource use are not consistently reported and are limited to hospital stay and operating room time. More reporting on hospital resources e.g., intensive care use, blood products and consumables used in treatment of complications, can assist decision makers understand the broader costs of the procedure in the patient treatment pathway.

Conference/Value in Health Info

2023-05, ISPOR 2023, Boston, MA, USA

Value in Health, Volume 26, Issue 6, S2 (June 2023)

Code

EE4

Topic

Economic Evaluation, Medical Technologies, Study Approaches

Topic Subcategory

Literature Review & Synthesis, Medical Devices

Disease

Medical Devices, Surgery

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×